Collaborative research into the causes of early-onset bowel cancer received a significant boost today with the establishment of an inaugural $5.8 million Early-Onset Bowel Cancer Centre of Research Excellence. To be known as the Centre of Research Excellence (CRE) ARTEMIS, the Centre’s five-year research program will investigate the aetiology, risk factors, tumourigenesis, exposures, microbiome and immune susceptibilities that are underlying early-onset bowel cancer. Bowel Cancer Australia has committed $3 million to establish one of the nation’s most esteemed and leading team of researchers, clinicians, and people with lived experience who will collaborate to identify what is causing the alarming increase in early-onset bowel cancer. “One of Bowel Cancer Australia’s key objectives in establishing CRE ARTEMIS is to put Australia at the forefront of research efforts that would lead to improved outcomes for young people here and globally. The Centre will create a focal point of expertise that fosters and facilitates national collaborative research endeavours focused on the causes of the increase in early-onset bowel cancer. CRE ARTEMIS is a 100% community funded research initiative made possible thanks to the generous support of the charity’s donors and fundraisers.” ~ Julien Wiggins (CEO, Bowel Cancer Australia) The Centre was named after the Greek goddess of the hunt, Artemis, reflecting the team’s determination to track down what is causing early-onset bowel cancer and the alarming rise of the disease in young Australians. artemiscre.org